Stock NANOFH NANOFORM FINLAND OYJ
Add to a list
To use this feature you must be a member
Log inSign up

News Nanoform Finland Oyj

Equities

NANOFH

FI4000330972

Market Closed - Nasdaq Helsinki
Other stock markets
 11:29:40 2024-04-18 am EDT 		5-day change 1st Jan Change
2.465 EUR -2.38% Intraday chart for Nanoform Finland Oyj -7.85% +55.52%
Apr. 11 Nanoform Finland to Deliver Nanomedicine Technology to Japan MT
Apr. 11 Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
AQ
Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024
AQ
Nanoform Finland to Deliver Nanomedicine Technology to Japan
MT
Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan
AQ
Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan
CI
Nanoform Teams Up with PlusVitech to Repurpose Anti-Nausea Drug for Lung Cancer Treatment
MT
Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer
AQ
Nanoform Finland plc and Plusvitech Partner to Repurpose Aprepitant as A Treatment for Lung Cancer
CI
Nanoform Finland Plc: Certified Adviser change to Carnegie Investment Bank Ab
AQ
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals
AQ
Notice to the Annual General Meeting of NANOFORM FINLAND Plc
AQ
Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 and 1/2020
AQ
Nanoform Finland Plc - Manager's transactions - Miguel Calado
AQ
Nanoform Finland Plc - Manager's transactions - Mads Laustsen
AQ
Nanoform Finland Plc - Manager's transactions - Albert Hæggström
AQ
Nanoform Finland Plc - Manager's transactions - Jeanne Thoma
AQ
Nanoform Finland Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Nanoform Finland Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Transcript : Nanoform Finland Oyj, 2023 Earnings Call, Feb 29, 2024
Apalutamide Study Again Demonstrates the Advantages of Nanoforming Over Traditional Cancer Treatment Formulations
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NANOFH Stock
  4. News Nanoform Finland Oyj